Zedira&s;s specialty reagents for R+D purposes support researchers in academia and industry
Business Model:
Revenue: $4.4M
Employees: 51-200
Address:
City: Darmstadt
State: Hessen
Zip:
Country: Germany
Zedira GmbH is a clinical stage biotech company that specializes in transglutaminase. The company develops small molecular drug candidates and engages in the discovery of small molecules that block dysregulated transglutaminases. It is a global brand for specialty reagents for research and development as well as diagnostics in the transglutaminase field. They offer TG6, a neuronal transglutaminase marker used in detecting neurological disorders caused by gluten. The company also produces and markets specialty reagents to assist investigators who are studying celiac disease; and develops active ingredients and celiac disease diagnostic antigens. ZEDIRA GmbH also provides proteases, assays, substrates, antibodies, inhibitors, and autoantibody detection ELISA-Kits. Zedira was founded by Ralf Pasternack and Martin Hils in 2007; and is headquartered in Hessen, Germany.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Grant | 1 | $1.6M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
5/2010 | Seed Round | 1 | - |
High-Tech Grunderfonds High-Tech Grunderfonds |
5/2010 | Seed Round | 1 | - |
High-Tech Grunderfonds High-Tech Grunderfonds |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|